4//SEC Filing
Konidaris Tasos 4
Accession 0001628280-25-011303
CIK 0001723128other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:17 PM ET
Size
5.0 KB
Accession
0001628280-25-011303
Insider Transaction Report
Form 4
Konidaris Tasos
Executive Vice President & CFO
Transactions
- Sale
Class A Common Stock
2025-03-05$8.91/sh−100,000$891,000→ 621,882 total
Footnotes (1)
- [F1]The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.84 to $8.98 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001320982
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:17 PM ET
- Size
- 5.0 KB